High-dose chemotherapy with autologous stem cell support for breast cancer: a review of the Dana-Farber Cancer Institute/Beth Israel Hospital experience.

Find People
Find Research
Overview
Tutorials
FAQs
Edit My PROFILE
Login to PROFILES

Contact Us
If you have any questions or feedback please contact us.

High-dose chemotherapy with autologous stem cell support for breast cancer: a review of the Dana-Farber Cancer Institute/Beth Israel Hospital experience.

Ayash LJ, Elias A, Wheeler C, Tepler I, Schwartz G, Schnipper L, Frei E, Antman K. High-dose chemotherapy with autologous stem cell support for breast cancer: a review of the Dana-Farber Cancer Institute/Beth Israel Hospital experience. J Hematother. 1993; 2(4):507-11.

View in: PubMed

subject areas

Adenocarcinoma
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Blood Transfusion, Autologous
Bone Marrow Diseases
Boston
Breast Neoplasms
Carboplatin
Clinical Trials, Phase I as Topic
Clinical Trials, Phase II as Topic
Combined Modality Therapy
Cyclophosphamide
Feasibility Studies
Female
Hematopoietic Cell Growth Factors
Hematopoietic Stem Cell Transplantation
Humans
Immunologic Factors
Middle Aged
Neoplasm Staging
Pilot Projects
Randomized Controlled Trials as Topic
Remission Induction
Retrospective Studies
Survival Analysis
Thiotepa
Treatment Outcome

authors with profiles

Anthony David Elias

Contact Us
CCTSI
About CCTSI
CCTSI Affiliated Institutions
National CTSA Consortium